Thilo Gambichler Selected Research

Lichen Sclerosus et Atrophicus (Lichen Sclerosus)

7/2013	Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
3/2013	Association of autoimmune diseases with lichen sclerosus in 532 male and female patients.
11/2009	Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus.
9/2007	Narrowband UV-B phototherapy for extragenital lichen sclerosus.
10/2004	Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
9/2004	UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.
2/2002	Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thilo Gambichler Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 02/2003
22	Melanoma (Melanoma, Malignant) 01/2022 - 11/2008
12	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 08/2002
11	Merkel Cell Carcinoma 11/2022 - 01/2018
11	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2002
11	Localized Scleroderma (Morphea) 01/2021 - 02/2002
10	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 12/2002
9	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2009
7	Atopic Dermatitis (Atopic Eczema) 11/2022 - 08/2002
7	Cutaneous Lupus Erythematosus 01/2021 - 09/2004
7	Skin Diseases (Skin Disease) 09/2020 - 02/2002
7	Erythema 01/2018 - 06/2002
7	Inflammation (Inflammations) 06/2016 - 08/2002
7	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 07/2013 - 02/2002
6	Hidradenitis Suppurativa 01/2022 - 11/2012
6	Infections 01/2022 - 04/2004
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2012
4	Pain (Aches) 12/2017 - 10/2004
4	Pigmented Nevus (Melanocytic Nevus) 01/2013 - 05/2009
4	Cutaneous Malignant Melanoma 01/2013 - 11/2008
4	Nephrogenic Fibrosing Dermopathy 06/2010 - 11/2008
4	Dysplastic Nevus Syndrome (Dysplastic Nevus) 06/2009 - 11/2008
3	Disease Progression 04/2021 - 01/2016
3	Actinic Keratosis 01/2021 - 01/2018
3	Carcinogenesis 01/2020 - 09/2004
3	Nevus (Nevi) 06/2009 - 11/2008
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022 - 12/2021
2	Lymphoma (Lymphomas) 01/2022 - 01/2006
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 07/2013
2	COVID-19 11/2020 - 01/2020
2	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020 - 01/2005
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2005
2	Body Weight (Weight, Body) 01/2020 - 10/2004
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2019 - 01/2016
2	Pruritus (Itching) 06/2014 - 09/2006
2	Hyperhidrosis 05/2012 - 08/2007
2	Nausea 06/2011 - 03/2009
2	HIV Infections (HIV Infection) 04/2011 - 01/2008
2	Wounds and Injuries (Trauma) 03/2009 - 03/2006
2	Granuloma Annulare 09/2006 - 03/2002
1	Mycosis Fungoides 08/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
12	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2016
12	Messenger RNA (mRNA)IBA 01/2021 - 10/2006
12	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2009
8	Biomarkers (Surrogate Marker)IBA 08/2022 - 09/2010
7	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 03/2002
6	NivolumabIBA 05/2022 - 12/2017
5	IpilimumabIBA 05/2022 - 01/2016
5	ParaffinIBA 01/2021 - 11/2008
5	CytokinesIBA 09/2020 - 09/2008
5	FumaratesIBA 05/2016 - 03/2002
4	AntibodiesIBA 01/2022 - 05/2012
4	Antimicrobial PeptidesIBA 09/2020 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2008
4	LigandsIBA 01/2018 - 10/2010
3	CollagenIBA 01/2022 - 08/2002
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 09/2008
3	Interleukin-8 (Interleukin 8)IBA 11/2012 - 09/2008
3	Interleukin-6 (Interleukin 6)IBA 11/2012 - 09/2008
3	Interleukin-10 (Interleukin 10)IBA 11/2012 - 09/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 10/2006
3	DecorinIBA 07/2009 - 06/2007
3	pimecrolimus (Elidel)FDA Link 09/2006 - 09/2004
2	Phosphopyruvate Hydratase (Enolase)IBA 11/2022 - 05/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2021 - 01/2020
2	SaltsIBA 01/2021 - 05/2020
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2020
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 09/2020 - 03/2010
2	avelumabIBA 01/2020 - 01/2018
2	Interleukin-2 (IL2)IBA 10/2018 - 09/2008
2	Circular RNAIBA 09/2016 - 01/2016
2	EnzymesIBA 07/2016 - 07/2010
2	Ribonuclease III (RNase III)IBA 07/2016 - 01/2011
2	AutoantibodiesIBA 02/2016 - 03/2013
2	Interleukin-33IBA 01/2013 - 10/2010
2	Adenosine Monophosphate (AMP)IBA 11/2012 - 07/2011
2	Chemokine CCL5IBA 10/2011 - 10/2010
2	Antimalarials (Antimalarial Agents)IBA 06/2011 - 03/2009
2	Cell Adhesion MoleculesIBA 10/2010 - 06/2009
2	InterferonsIBA 10/2010 - 01/2006
2	Contrast MediaIBA 06/2010 - 10/2009
2	GadoliniumIBA 06/2010 - 10/2009
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 07/2005
2	Chloroquine (Aralen)FDA LinkGeneric 03/2009 - 12/2002
2	Ficusin (Psoralen)IBA 04/2005 - 03/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2005 - 10/2004
1	MART-1 AntigenIBA 05/2022
1	DesminIBA 05/2022
1	tagraxofuspIBA 01/2022

Therapy/Procedure

31	Therapeutics 01/2022 - 02/2002
16	Phototherapy (Light Therapy) 01/2018 - 02/2002
7	Photopheresis 11/2022 - 08/2002
3	Radiotherapy 01/2022 - 05/2019
3	Immunotherapy 01/2020 - 10/2018
3	Renal Dialysis (Hemodialysis) 06/2010 - 03/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2003
2	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 02/2003
2	Baths 05/2020 - 05/2007
1	Mastectomy (Mammectomy) 05/2022